Raphael Pharmaceutical Inc.
RAPH
Revenue
0.00
0.000.00%
-Assets
128.00k
▼-225.00k▼-63.74%
3 Months ChangeLiabilities
418.00k
▼-38.00k▼-8.33%
3 Months ChangeFree Cash Flow
-173.00k
▼-173.00k-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-11
Form 8-K
ID: 0001213900-24-077706
2024-08-12
Form 10-Q
ID: 0001213900-24-067723
2024-06-26
Form 8-K
ID: 0001213900-24-056191
2024-05-15
Form 10-Q
ID: 0001213900-24-043557
2024-05-02
Form 8-K
ID: 0001213900-24-039106
2023-11-14
Form 10-Q
ID: 0001213900-23-086894
2023-08-09
Form 10-Q
ID: 0001213900-23-065005
2023-05-15
Form 10-Q
ID: 0001213900-23-039833
2023-03-28
Form 8-K
ID: 0001213900-23-023667
2022-11-14
Form 10-Q
ID: 0001213900-22-071861